The GBLX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GBLX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The GBLX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View GBLX Detailed Price Forecast - CNN Money
|View GBLX Detailed Summary - Google Finance
|View GBLX Detailed Summary - Yahoo! Finance
|View GBLX Stock Research & Analysis - Zacks.com
|View GBLX Trends & Analysis - Trade-Ideas
|View GBLX Major Holders - Barrons
|View GBLX Call Transcripts - NASDAQ
|View GBLX Breaking News & Analysis - Seeking Alpha
|View GBLX Annual Report - CompanySpotlight.com
|View GBLX OTC Short Report - OTCShortReport.com
|View GBLX Fundamentals - TradeKing
|View GBLX SEC Filings - Bar Chart
|View Historical Prices for GBLX - The WSJ
|View Performance/Total Return for GBLX - Morningstar
|View the Analyst Estimates for GBLX - MarketWatch
|View the Earnings History for GBLX - CNBC
|View the GBLX Earnings - StockMarketWatch
|View GBLX Buy or Sell Recommendations - MacroAxis
|View the GBLX Bullish Patterns - American Bulls
|View GBLX Short Pain Metrics - ShortPainBot.com
|View GBLX Stock Mentions - StockTwits
|View GBLX Stock Mentions - PennyStockTweets
|View GBLX Stock Mentions - Twitter
|View GBLX Investment Forum News - Investor Hub
|View GBLX Stock Mentions - Yahoo! Message Board
|View GBLX Stock Mentions - Seeking Alpha
|View Insider Transactions for GBLX - SECform4.com
|View Insider Transactions for GBLX - Insider Cow
|View GBLX Major Holdings Summary - CNBC
|View Insider Disclosure for GBLX - OTC Markets
|View Insider Transactions for GBLX - Yahoo! Finance
|View Institutional Holdings for GBLX - NASDAQ
|View GBLX Stock Insight & Charts - FinViz.com
|View GBLX Investment Charts - StockCharts.com
|View GBLX Stock Overview & Charts - BarChart
|View GBLX User Generated Charts - Trading View
Gb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)
Posted on Thursday December 14, 2023
Tune in this Sunday, Dec. 17, at 5:30 p.m. ET on the Fox Business Network to learn about Gb Sciences' cannabinoid-based medicine for the treatment of Parkinson's disease.LAS VEGAS, NV / ACCESSWIRE / December 14, 2023 / Gb Sciences, Inc. (OTCQB:GBLX), ...
Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has successfully completed a dose response study in rodents at the University of Lethbridge that supports Gb Sciences' cannabinoid-based therapy for Parkinson's disease. The study has established dose ranges and the corresponding times to onset and duration of action in a rodent model.
Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has recently been issued a patent in China to protect its proprietary cannabinoid-containing formulation for the treatment of Parkinson's disease. China is an increasingly important pharmaceutical market with cultural acceptance of plant-based formulations, which is a good fit for Gb Sciences' drug candidates.
Successful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery Platform
Posted on Tuesday March 07, 2023
Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, issued a letter to shareholders today from President, Chief Science Officer, and Director Dr. Andrea Small-Howard and Chairman and CEO John Poss summarizing key developments from 2022 and providing strategic plans for 2023.